Skip to main content
Premium Trial:

Request an Annual Quote

Defense Dept. Pays ABI $24.5M to Develop Pathogen-Detection Test

NEW YORK (GenomeWeb News) — The US Department of Defense has awarded Applied Biosystems a $24.5 million contract to develop a prototype system that can identify infectious diseases for epidemiological and biosecurity purposes.
 
ABI said the company has already presented “key components” of the prototype to the United States Air Force, which will validate it.
 
According to ABI, the system will use a multiplex assay to identify emerging pathogens. Early prototypes can already ID 10 pathogens simultaneously on a test array, the firm said.
 
The company added that, once completed, the system could be used in other applications in biosecurity, forensics, animal testing, and food quality testing --- applied markets that ABI hopes will fatten its top line over the next two years.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.